TXG
10X Genomics Inc
85.70$
+1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -16.5% | 14.0% | -11.2% | 4.9% | 14.3% | -4.1% | 22.2% | 10.2% | 29.0% | 24.6% | 17.3% | 11.2% | 20.6% | |
| 7.4% | 6.4% | 8.2% | 7.1% | 7.1% | 6.4% | 6.3% | 5.6% | 8.2% | 7.3% | 7.9% | 5.1% | 7.1% | |
| 26.2% | 21.2% | 25.6% | 25.1% | 22.1% | 19.7% | 20.1% | 15.9% | 17.0% | 15.2% | 15.0% | 17.0% | 16.0% | |
| 26.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 10.5% | 9.3% | -4.5% | -2.7% | 8.6% | -0.8% | 18.3% | -31.1% | 21.3% | 11.2% | 3.5% | -2.7% | 8.4% | |
| 10.0% | 1.9% | 2.1% | 2.5% | 2.6% | 1.6% | 1.2% | 0.9% | 0.5% | 1.1% | 1.1% | 1.1% | 0.9% | |
| 3.2% | 7.1% | 7.5% | 7.8% | -2.4% | -31.3% | -1.2% | -0.5% | -5.9% | -1.1% | -0.9% | -5.1% | -3.2% | |
| 2.8% | 3.1% | 1.2% | 3.0% | 0.1% | 2.7% | 0.3% | 2.0% | 0.4% | 1.4% | -5.6% | 2.0% | -0.4% | |
| -10.5% | 24.2% | -2.5% | 15.7% | 12.1% | -32.8% | 21.3% | 11.9% | 23.5% | 24.8% | 10.8% | 8.1% | 17.0% | |
| -26.5% | 12.1% | -13.2% | 2.4% | 11.7% | -5.7% | 21.0% | 9.3% | 28.5% | 23.5% | 16.3% | 10.2% | 19.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.